Advertisement

Novel and Selective Inhibitors of CaM-Kinase II and Other Calmodulin-Dependent Enzymes

  • Hiroyoshi Hidaka
  • Masatoshi Hagiwara
  • Hiroshi Tokumitsu
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 269)

Abstract

Twenty years has passed since two laboratories working independently on the purification of cyclic nucleotide phosphodiesterase reported the existence of a protein factor that activated enzymatic activity (1, 2). These early observations are credited the discovery of calmodulin. Biopharmacological studies using calmodulin antagonists such as naphthalenesulfonamides and phenothiazines have facilitated an insight into calmodulin function, not only in vitro but also in vivo. Phenothiazines were the first antagonists of calmodulin to be reported (3), although they have multiple macromolecular targets inside cells such as membranes (4), albumin (5), dehydrogenases (6), and dopamine receptors (7).

Keywords

Myosin Light Chain Myosin Light Chain Kinase Cyclic Nucleotide Phosphodiesterase Phosphorylates Myosin Light Chain Calmodulin Antagonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    S. Kakiuchi, and R. Yamazaki, Biochem. Biophys. Res. Commun. 41:1104 (1970).PubMedCrossRefGoogle Scholar
  2. 2.
    W.Y. Cheung. Biochem. Biophys. Res. Commun. 38: 533 (1970).PubMedCrossRefGoogle Scholar
  3. 3.
    F. Honda, S. Katsuki, and N. Sakai. Jpn. J. Pharmacol. Suppl. 23: 27 (1973).Google Scholar
  4. 4.
    P. Seeman. Pharmacol. Rev. 24: 583 (1972).PubMedGoogle Scholar
  5. 5.
    S. Gabay, and P. C. Hung, in: “The Phenothiazines and Structurally Related Drugs”, I. S. Forrest, D. J. Carr, and Usdin, eds., pp. 175–189, Raven Press, New York (1974).Google Scholar
  6. 6.
    F. M. Veronese, R. Bevilacqua, and I. M. Chaiken. Mol. Pharmacol. 15: 313 (1979).PubMedGoogle Scholar
  7. 7.
    J. Giesecke, and H. Hebert. O. Rev. Biophys. 12: 263 (1979).CrossRefGoogle Scholar
  8. 8.
    H. Hidaka, T. Yamaki, M. Naka, T. Tanaka, H. Hayashi, and R. Kobayashi, Mol. Pharmacol. 17: 66 (1980).PubMedGoogle Scholar
  9. 9.
    T. Tanaka, H. Umekawa, M. Saitoh, T. Ishikawa, T. Shin, M. Ito, Y. Kawamatsu, H. Sugihara, and H. Hidaka. Mol. Pharmacol. 29: 264 (1986).PubMedGoogle Scholar
  10. 10.
    H. Itoh, T. Ishikawa, and H. Hidaka, J. Pharmacol. Exp. Ther. 230: 737 (1984).PubMedGoogle Scholar
  11. 11.
    H. Umekawa, K. Yamakawa, K. Nunoki, N. Taira, T. Tanaka, and H. Hidaka, Biochemical. Pharmacol. 37: 3377 (1988).CrossRefGoogle Scholar
  12. 12.
    M. Hagiwara, T. Endo, and H. Hidaka. Biochem. Pharmacol. 33: 453 (1984).PubMedCrossRefGoogle Scholar
  13. 13.
    T. Tanaka, E. Yamada, T. Sone, and H. Hidaka. Biochemistry 22:1030 (1983).PubMedCrossRefGoogle Scholar
  14. 14.
    R. S. Adelstein, and E. Eisenberg. Annu. Rev. Biochem. 49: 921 (1980).PubMedCrossRefGoogle Scholar
  15. 15.
    M. Hagiwara, H. Tokumitsu, K. Onoda, T. Tanaka, M. Ito, N. Kato, and H. Hidaka, J. Biochem. (in press) (1989).Google Scholar
  16. 16.
    M. Saitoh, T. Ishikawa, S. Matsushima, M. Naka, and H. Hidaka. J. Biol. Chem. 262: 7796 (1987).PubMedGoogle Scholar
  17. 17.
    M. Hagiwara, M. Inagaki, M. Watanabe, M. Ito, K. Onoda, T. Tanaka, and H. Hidaka, Mol. Pharmacol. 32: 7 (1987).PubMedGoogle Scholar
  18. 18.
    M. Hagiwara, S. Inoue, T. Tanaka, K. Nunoki, M. Ito, and H. Hidaka, Biochem. Pharmacol. 37: 2987 (1988).PubMedCrossRefGoogle Scholar
  19. 19.
    C. B. Klee, and T. C. Vanaman. Adv. Protein Chem. 35, 213 (1982).PubMedCrossRefGoogle Scholar
  20. 20.
    M. Hagiwara, S. Mamiya, and H. Hidaka. J. Biol. Chem. 264: 40 (1989).PubMedGoogle Scholar
  21. 21.
    S. Mamiya, M. Hagiwara, S. Inoue, and H. Hidaka. J. Biol. Chem. 264:8575 (1989).PubMedGoogle Scholar
  22. 22.
    T. Endo, and H. Hidaka. Biochem. Biophys. Res. Commun. 97: 553 (1980).PubMedCrossRefGoogle Scholar
  23. 23.
    T. Yamauchi, H. Fujisawa, FEBS Lett. 129:117 (1981).PubMedCrossRefGoogle Scholar
  24. 24.
    M. B. Kennedy. Annu. Rev. Neurosci. 6: 493 (1983).PubMedCrossRefGoogle Scholar
  25. 25.
    A. C. Narin, H. C. Hemmings, Jr., and P. Greengard. Annu. Rev. Biochem. 54: 931 (1985).CrossRefGoogle Scholar
  26. 26.
    H. Tokumitsu, T. Chijiwa, M. Hagiwara, A. Mizutani, and Hidaka, H. (submitted).Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Hiroyoshi Hidaka
    • 1
  • Masatoshi Hagiwara
    • 1
  • Hiroshi Tokumitsu
    • 1
  1. 1.Department of PharmacologyNagoya University, School of MedicineShowa-ku, Nagoya 466Japan

Personalised recommendations